Skip to main content

Life sciences/Biochemistry/Pharmacology/Drug development/Drug candidates

The findings suggest a way to develop new vaccines — or repurpose existing drugs — against the virus.

By returning to traditional screening methods, researchers have identified an effective anti-malarial drug candidate, known as NITD609, which seems to kill the blood stages of the two major malaria parasites when administered orally, just once a day. This discovery is especially timely since researchers in Asia have begun to report a building resistance to artemisinin, the main ingredient in current malaria treatments for about 100 million patients each year.